(Q34150824)

English

Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

AIDS-related Kaposi's sarcoma

1 reference

based on heuristic

inferred from title

Gillian M Keating

3

object named as

Gillian M Keating

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Miriam Sharpe

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stephanie E Easthope

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Harriet M Lamb

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2089-2126

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200262140-00012

0 references

Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracycline-binding induced DNA stiffening, bending and elongation; stereochemical implications from viscometric investigations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomes. Opportunities in drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Key issues in the treatment of advanced breast cancer. Expectations and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of caelyx (liposomal doxorubicin) in metastatic carcinoma of the prostate: tolerability and efficacy modification by liposomal encapsulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of Doxil and vinorelbine in metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology, prevention, and early detection of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal anthracyclines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New developments in chemotherapy of advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracyclines in the treatment of cancer. An overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AIDS-related Kaposi's sarcoma: current treatment options, future trends.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of a modified chemotherapeutic regimen containing vincristine, liposomal doxorubicin and dexamethasone to multiple myeloma patients: preliminary data

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracycline Efficacy in vitro: Cytotoxicity of Liposomal/Nonliposomal Daunorubicin and Doxorubicin for Multiple Tumor Cell Types

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin in sterically stabilized liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN Practice Guidelines for Breast Cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of prognostic factors in non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel: an update of its use in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on the management of advanced breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracycline cardiotoxicity, no longer an issue?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of intravenous Doxil in malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update of the NCCN ovarian cancer practice guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining new agents with anthracyclines in metastatic breast cancer: an overview of recent findings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal daunorubicin:in vitro andin vivo efficacy in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety aspects of pegylated liposomal doxorubicin in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caelyx in malignant mesothelioma: a phase II EORTC study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of liposomal doxorubicin in advanced gynecologic cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin's lymphoma in the elderly: a guide to drug treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylaxis and therapy of mouse mammary carcinomas with doxorubicin and vincristine encapsulated in sterically stabilised liposomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current drug treatment guidelines for epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strategies for reduction of anthracycline cardiac toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269857

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200262140-00012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34150824&oldid=1966328223"